PCT and sTREM-1: The markers of infection in critically ill patients?

Medical Science Monitor

Volumn 14, Issue 12, 2008, Pages

  Schultz, Marcus J ^a,b   Determann, Rogier M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Biomarkers; Infection; Intensive Care Medicine; Pneumonia; Sepsis

Indexed keywords

BIOLOGICAL MARKER; PROCALCITONIN; SOLUBLE TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG;

ABDOMINAL INFECTION; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM CULTURE; BONE INFECTION; CATHETER INFECTION; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HOSPITAL INFECTION; HUMAN; INDWELLING CATHETER; INFECTION; INFECTIOUS ARTHRITIS; INTENSIVE CARE; LABORATORY TEST; PNEUMONIA; RESPIRATORY TRACT INFECTION; REVIEW; SEPSIS; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

BIOLOGICAL MARKERS; CALCITONIN; CRITICAL ILLNESS; HUMANS; MEMBRANE GLYCOPROTEINS; PROTEIN PRECURSORS; RECEPTORS, IMMUNOLOGIC;

EID: 57349120097     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Uzzan B, Cohen R, Nicolas P et al: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med, 2006; 34: 1996-2003
2. de Werra I, Jaccard C, Corradin SB et al: Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med, 1997; 25: 607-13
3. Benoist JF, Mimoz O, Assicot M, Edouard A: Serum procalcitonin, but not C-reactive protein, identifies sepsis in trauma patients. Clin Chem, 1998; 44: 1778-79
4. Whang KT, Steinwald PM, White JC et al: Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab, 1998; 83: 3296-301
5. Rothenburger M, Markewitz A, Lenz T et al: Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein. Clin Chem Lab Med, 1999; 37: 275-79
6. Ugarte H, Silva E, Mercan D et al: Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med, 1999; 27: 498-504
7. Adamik B, Kubler-Kielb J, Golebiowska B et al: Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med, 2000; 26: 1259-67
8. Aouifi A, Piriou V, Bastien O et al: Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med, 2000; 28: 3171-76
9. Baykut D, Schulte-Herbruggen J, Krian A: The value of procalcitonin as an infection marker in cardiac surgery. Eur J Med Res, 2000; 5: 530-36
10. Boeken U, Feindt P, Micek M et al: Procalcitonin (PCT) in cardiac surgery: diagnostic value in systemic inflammatory response syndrome (SIRS), sepsis and after heart transplantation (HTX). Cardiovasc Surg, 2000; 8: 550-54
11. Brunkhorst FM, Wegscheider K, Forycki ZF: Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med, 2000; 26: S148-52
12. Cheval C, Timsit JF, Garrouste-Orgeas M: Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients. Intensive Care Med 2000, 2000; 26: S153-58
13. Suprin E, Camus C, Gacouin A et al: Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med, 2000; 26: 1232-38
14. Reith HB, Mittelkotter U, Wagner R: Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med, 2000; 26: S165-69
15. Selberg O, Hecker H, Martin M et al: Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med, 2000; 28: 2793-98
16. Muller B, Becker KL, Schachinger H et al: Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med, 2000; 28: 977-83
17. Oberhoffer M, Russwurm S, Bredle D: Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points. Intensive Care Med, 2000; 26: S170-74
18. Wanner GA, Keel M, Steckholzer U et al: Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med, 2000; 28: 950-57
19. Harbarth S, Holeckova K, Froidevaux C et al: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med, 2001; 164: 396-402
20. Yukioka H, Yoshida G, Kurita S: Plasma procalcitonin in sepsis and organ failure. Ann Acad Med Singapore, 2001; 30: 28-31
21. Giamarellos-Bourboulis EJ, Mega A, Grecka P et al: Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med, 2002; 28: 1351-56
22. Meisner M, Rauschmayer C, Schmidt J et al: Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med, 2002; 28: 1094-102
23. Ruokonen E, Ilkka L, Niskanen M, Takala J: Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand, 2002; 46: 398-404
24. Tugrul S, Esen F, Celebi S et al: Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response. Anaesth Intensive Care, 2002; 30: 747-54
25. Dorge H, Schondube FA, Dorge P et al: Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection. Thorac Cardiovasc Surg, 2003; 51: 322-26
26. Du B, Pan J, Chen D, Li Y: Serum procalcitonin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and non-infectious origin. Chin Med J (Engl), 2003; 116: 538-42
27. Balc IC, Sungurtekin H, Gurses E et al: Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care, 2003; 7: 85-90
28. De Talance N, Burlet C, Claudel C: La procalcitonine (PCT) est-elle le marqueur spécifique du choc septique? Immunoanalyse et Biologie Spécialisée, 2003; 18: 120-22
29. Geppert A, Steiner A, Delle-Karth G et al: Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med, 2003; 29: 1384-89
30. Hensler T, Sauerland S, Lefering R et al: The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma. Shock, 2003; 20: 420-26
31. Kabir K, Keller H, Grass G et al: Cytokines and chemokines in serum and urine as early predictors to identify septic patients on intensive care unit. Int J Mol Med, 2003; 12: 565-70
32. Luzzani A, Polati E, Dorizzi R et al: Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med, 2003; 31: 1737-41
33. Castelli GP, Pognani C, Meisner M et al: Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care, 2004; 8: R234-42
34. Clec'h C, Ferriere F, Karoubi P et al: Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med, 2004; 32: 1166-69
35. Tang BM, Eslick GD, Craig JC, McLean AS: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis, 2007; 7: 210-17
36. Baumgarten R, Pequeriaux NC, Van Puyenbroek MJ, Speelberg B: [Is procalcitonine van additionele waarde bij de diagnostiek van sepsis?]. Ned Tijdschr Klin Chem, 2002; 27: 32-35
37. Al-Nawas B, Krammer I, Shah PM: Procalcitonin in diagnosis of severe infections. Eur J Med Res, 1996; 1: 331-33
38. Bossink AW, Groeneveld AB, Thijs LG: Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis, 1999; 29: 398-407
39. Hausfater P, Garric S, Ayed SB et al: Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis, 2002; 34: 895-901
40. Chan YL, Tseng CP, Tsay PK et al: Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care, 2004; 8: R12-20
41. Gibot S, Kolopp-Sarda MN, Bene MC et al: Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med, 2004; 141: 9-15
42. Aikawa N, Fujishima S, Endo S et al: Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother, 2005; 11: 152-59
43. Mokart D, Merlin M, Sannini A et al: Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth, 2005; 94: 767-73
44. Muller B, Christ-Crain M, Schuetz P: Meta-analysis of procalcitonin for sepsis detection. Lancet Infect Dis, 2007; 7: 498-99; author reply 502-3
45. Jensen JU, Lundgren B, Lundgren JD: Meta-analysis of procalcitonin for sepsis detection. Lancet Infect Dis, 2007; 7: 499-500; author reply 502-3
46. Reinhart K, Brunkhorst FM: Meta-analysis of procalcitonin for sepsis detection. Lancet Infect Dis, 2007; 7: 500-2; author reply 502-3
47. Nobre V, Harbarth S, Graf JD et al: Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med, 2008; 177: 498-505
48. Christ-Crain M, Jaccard-Stolz D, Bingisser R et al: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet, 2004; 363: 600-7
49. Soderquist B, Jones I, Fredlund H, Vikerfors T: Bacterial or crystal-associated arthritis? Discriminating ability of serum inflammatory markers. Scand J Infect Dis, 1998; 30: 591-96
50. van Dissel JT: Procalcitonin: what should be its role in the clinical management of febrile patients admitted to the hospital? Clin Infect Dis, 2003; 36: 824-25; author reply 826-27
51. Mimoz O, Benoist JF, Edouard AR et al: Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med, 1998; 24: 185-88
52. Arkader R, Troster EJ, Abellan DM et al: Procalcitonin and C-reactive protein kinetics in postoperative pediatric cardiac surgical patients. J Cardiothorac Vasc Anesth, 2004; 18: 160-65
53. Brunkhorst FM, Eberhard OK, Brunkhorst R: Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med, 1999; 27: 2172-76
54. Stiletto RJ, Baacke M, Gotzen L et al: Procalcitonin versus interleukin-6 levels in bronchoalveolar lavage fluids of trauma victims with severe lung contusion. Crit Care Med, 2001; 29: 1690-93
55. Eberhard OK, Langefeld I, Kuse ER et al: Procalcitonin in the early phase after renal transplantation - will it add to diagnostic accuracy? Clin Transplant, 1998; 12: 206-11
56. Nylen ES, Al Arifi A, Becker KL et al: Effect of classic heatstroke on serum procalcitonin. Crit Care Med, 1997; 25: 1362-65
57. Gibot S, Cravoisy A, Kolopp-Sarda MN et al: Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med, 2005; 33: 792-96
58. Luyt CE, Guerin V, Combes A et al: Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med, 2005; 171: 48-53
59. Christ-Crain M, Stolz D, Bingisser R et al: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med, 2006; 174: 84-93
60. Stolz D, Christ-Crain M, Bingisser R et al: Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest, 2007; 131: 9-19
61. Richeldi L, Mariani M, Losi M et al: Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J, 2004; 24: 247-50
62. Gibot S, Cravoisy A, Levy B et al: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med, 2004; 350: 451-58
63. Determann RM, Millo JL, Gibot S et al: Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med, 2005; 31: 1495-500
64. Muller B, Gencay MM, Gibot S et al: Circulating levels of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in community-acquired pneumonia. Crit Care Med, 2007; 35: 990-91
65. Gibot S, Cravoisy A, Dupays R et al: Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis. Scand J Infect Dis, 2007; 39: 604-8
66. Horonenko G, Hoyt JC, Robbins RA et al: Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest, 2007; 132: 58-63
67. Huh JW, Lim CM, Koh Y et al: Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltrates. Crit Care, 2008; 12: R6
68. Rau B, Kruger CM, Schilling MK: Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis. Langenbecks Arch Surg, 2004; 389: 134-44
69. Muller CA, Uhl W, Printzen G et al: Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis. Gut, 2000; 46: 233-38
70. Rau B, Steinbach G, Baumgart K et al: The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis. Intensive Care Med, 2000; 26: 159-64
71. Mandi Y, Farkas G, Takacs T et al: Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis. Int J Pancreatol, 2000; 28: 41-49
72. Riche FC, Cholley BP, Laisne MJ et al: Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis. Surgery, 2003; 133: 257-62
73. Makay R, Issekutz A, Banga P et al: [Role of procalcitonin rapid test in the differential diagnosis of uninfected and infected forms of acute pancreatitis]. Magy Seb, 2003; 56: 31-33
74. Ammori BJ, Becker KL, Kite P et al: Calcitonin precursors: early markers of gut barrier dysfunction in patients with acute pancreatitis. Pancreas, 2003; 27: 239-43
75. Schroder J, Staubach KH, Zabel P et al: Procalcitonin as a marker of severity in septic shock. Langenbecks Arch Surg, 1999; 384: 33-38
76. Determann RM, Schultz MJ, Geerlings SE: Soluble triggering receptor expressed on myeloid cells-1 is not a sufficient biological marker for infection of the urinary tract. J Infect, 2007; 54: e249-50
77. Fottner A, Birkenmaier C, von Schulze Pellengahr C et al: Can serum procalcitonin help to differentiate between septic and nonseptic arthritis? Arthroscopy, 2008; 24: 229-33
78. Butbul-Aviel Y, Koren A, Halevy R, Sakran W: Procalcitonin as a diagnostic aid in osteomyelitis and septic arthritis. Pediatr Emerg Care, 2005; 21: 828-32
79. Schuetz P, Mueller B, Trampuz A: Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection, 2007; 35: 352-55